Nature communications

How immune brain cells control fat metabolism in Alzheimer's disease shown by removing these cells in a mouse model

Updated

Abstract

selectively regulate lipid accumulation associated with Alzheimer's disease pathology in both mouse models and human brains.

  • Abnormal lipid metabolism is observed in Alzheimer's disease, but its role in disease progression is unclear.
  • Microglia influence lipid processing during Alzheimer's disease, impacting disease pathology.
  • A buildup of arachidonic acid-containing bis(monoacylglycero)phosphate is identified in response to amyloid plaques, dependent on microglial activity and the AD risk gene GRN.
  • Lysophosphatidylcholine and lysophosphatidylethanolamine accumulate independently of microglia, correlating with astrocyte activation and oxidative stress.
  • Dysregulated lipid metabolism in Alzheimer's disease is linked to specific brain cell types and molecular pathways.

Simplified

Key numbers

99%
Microglial reduction impact on P2Y12 area
Short-term treatment led to a near-complete elimination of .
−27%
Reduction in Aβ levels
Long-term treatment resulted in reduced Aβ levels.
−42%
Reduction in fibrillar plaque loads
Long-term treatment led to decreased fibrillar plaque loads.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free